去甲基化药物治疗失败的骨髓增生异常综合征患者中 IPSS-M 的表现。
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.
机构信息
Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
出版信息
Am J Hematol. 2023 Oct;98(10):E281-E284. doi: 10.1002/ajh.27043. Epub 2023 Jul 29.
PMID:37515433
Abstract
Evaluation of IPSS-M and exploratory prognostic model for MDS at the time of HMA failure.
摘要
HMA 失败时 MDS 的 IPSS-M 评估和探索性预后模型。
Zotero 插件